Tumor suppressor candidate 2 (TUSC2, FUS-1) and human cancers.

about

TUSC2 Immunogene Therapy Synergizes with Anti-PD-1 through Enhanced Proliferation and Infiltration of Natural Killer Cells in Syngeneic Kras-Mutant Mouse Lung Cancer Models.

P2860

Q50020811-40DD77B4-A4D1-4B02-B7B6-956BC4FF9616

P2860

Tumor suppressor candidate 2 (TUSC2, FUS-1) and human cancers.

Item

http://www.wikidata.org/entity/Q39439042

description

2017 nî lūn-bûn

@nan

2017年の論文

@ja

2017年学术文章

@wuu

2017年学术文章

@zh-cn

2017年学术文章

@zh-hans

2017年学术文章

@zh-my

2017年学术文章

@zh-sg

2017年學術文章

@yue

2017年學術文章

@zh

2017年學術文章

@zh-hant

name

Tumor suppressor candidate 2 (TUSC2, FUS-1) and human cancers.

@en

Tumor suppressor candidate 2 (TUSC2, FUS-1) and human cancers.

@nl

type

Item

label

Tumor suppressor candidate 2 (TUSC2, FUS-1) and human cancers.

@en

Tumor suppressor candidate 2 (TUSC2, FUS-1) and human cancers.

@nl

prefLabel

Tumor suppressor candidate 2 (TUSC2, FUS-1) and human cancers.

@en

Tumor suppressor candidate 2 (TUSC2, FUS-1) and human cancers.

@nl

P1476

Tumor suppressor candidate 2 (TUSC2, FUS-1) and human cancers.

@en

P2093

Alexandra Harrison

http://www.w3.org/2001/XMLSchema#string

Hui-Wen Lo

http://www.w3.org/2001/XMLSchema#string

Sherona Sirkisoon

http://www.w3.org/2001/XMLSchema#string

Tadas Rimkus

http://www.w3.org/2001/XMLSchema#string

P2860

Loss and reduction of FUS1 protein expression is a frequent phenomenon in the pathogenesis of lung cancer

Oncogenic activation of c-Abl in non-small cell lung cancer cells lacking FUS1 expression: inhibition of c-Abl by the tumor suppressor gene product Fus1

The 630-kb lung cancer homozygous deletion region on human chromosome 3p21.3: identification and evaluation of the resident candidate tumor suppressor genes. The International Lung Cancer Chromosome 3p21.3 Tumor Suppressor Gene Consortium

A novel radioprotective function for the mitochondrial tumor suppressor protein Fus1

Phase I clinical trial of systemically administered TUSC2(FUS1)-nanoparticles mediating functional gene transfer in humans

Loss of mitochondrial protein Fus1 augments host resistance to Acinetobacter baumannii infection

The tumor suppressor gene TUSC2 (FUS1) sensitizes NSCLC to the AKT inhibitor MK2206 in LKB1-dependent manner

Autoimmunity, spontaneous tumourigenesis, and IL-15 insufficiency in mice with a targeted disruption of the tumour suppressor gene Fus1

TUSC2(FUS1)-erlotinib Induced Vulnerabilities in Epidermal Growth Factor Receptor(EGFR) Wildtype Non-small Cell Lung Cancer(NSCLC) Targeted by the Repurposed Drug Auranofin

Myristoylation of the fus1 protein is required for tumor suppression in human lung cancer cells.

P304

325-330

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P433

128

http://www.w3.org/2001/XMLSchema#string

P478

http://www.w3.org/2001/XMLSchema#string

P577

2017-05-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

28715648

http://www.w3.org/2001/XMLSchema#string

P932

5808457

http://www.w3.org/2001/XMLSchema#string

Tumor suppressor candidate 2 (TUSC2, FUS-1) and human cancers.

about

P2860

P2860

Tumor suppressor candidate 2 (TUSC2, FUS-1) and human cancers.

description

name

type

label

prefLabel

P1433

P1476

P2093

P2860

P304

P31

P433

P478

P577

P698

P932

P1433

P1476

P2093

P2860

P304

P31

P433

P478

P577

P698

P932